Humulin LILLY R vial. 10ml

What is HUMLILR Humulin LILLY R vial. 10ml?

HUMLILR Humulin LILLY R vial. 10ml is a short-acting human insulin produced using recombinant DNA technology in a non-pathogenic strain of Escherichia coli. This sterile, clear, aqueous solution contains U-100 human insulin and is designed to help regulate blood glucose levels in people with type 1 or type 2 diabetes. As a rapid-onset insulin, it begins working within 30 minutes of injection, making it ideal for controlling post-meal blood sugar spikes. Manufactured by Eli Lilly, this vial delivers 100 units of insulin per milliliter, with each vial containing 10ml for multiple doses.

Key features

• Short-Acting Formula — Controls blood sugar spikes after meals with onset within 30 minutes.
• U-100 Concentration — Standard potency compatible with most insulin syringes and injection methods.
• rDNA Technology — Biosynthetic human insulin identical in structure to naturally produced insulin.
• Sterile Solution — Clear, colorless, and ready for injection without mixing.
• Veterinary Use — Can be prescribed for diabetic pets under veterinary supervision.
• 10ml Vial Size — Offers extended use and dose flexibility for regular insulin therapy.
• Prescription Required — Sold for medical use only with valid prescription documentation.

Who is HUMLILR Humulin LILLY R vial. 10ml for?

This insulin vial is intended for individuals managing diabetes who require short-acting insulin to control glucose levels around meal times. It's also suitable for veterinary use in diabetic pets when directed by a licensed veterinarian. Patients transitioning from animal-based insulins may benefit from its human-identical structure. It's best for users comfortable with vial-and-syringe administration rather than insulin pens.

How does HUMLILR Humulin LILLY R vial. 10ml compare?

Compared to long-acting or premixed insulins, Humulin R offers faster onset and shorter duration, making it ideal for mealtime coverage rather than baseline control. Unlike analog rapid-acting insulins like lispro or aspart, it has a slightly slower start and longer tail, which may affect precision in glucose management. When compared to standard polypropylene vials of other brands, it maintains consistent U-100 concentration and sterility. It is more cost-effective than analog insulins but requires more careful timing with meals.